Clearance concepts in pharmacokinetics.
作者信息
Rowland M, Benet L Z, Graham G G
出版信息
J Pharmacokinet Biopharm. 1973 Apr;1(2):123-36. doi: 10.1007/BF01059626.
PMID:4764426
Abstract
摘要
相似文献
1
Clearance concepts in pharmacokinetics.药代动力学中的清除概念。
J Pharmacokinet Biopharm. 1973 Apr;1(2):123-36. doi: 10.1007/BF01059626.
2
Classical pharmacokinetics to the frontier.经典药代动力学走向前沿。
J Pharmacokinet Biopharm. 1973 Oct;1(5):341-61. doi: 10.1007/BF01059663.
3
Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics.米氏方程及其积分形式在药代动力学中有用的性质。
J Pharmacokinet Biopharm. 1973 Apr;1(2):103-21. doi: 10.1007/BF01059625.
4
Effect of route of administration on drug disposition.给药途径对药物处置的影响。
J Pharmacokinet Biopharm. 1973 Oct;1(5):419-34. doi: 10.1007/BF01059666.
5
[Pharmacokinetic models].[药代动力学模型]
Tidsskr Nor Laegeforen. 1973 Jan 30;93(3):157-62.
6
A modern view of pharmacokinetics.药物动力学的现代观点。
J Pharmacokinet Biopharm. 1973 Oct;1(5):363-401. doi: 10.1007/BF01059664.
7
Drugs--some basic concepts.药物——一些基本概念。
Med Sci Sports Exerc. 1981;13(4):247-51. doi: 10.1249/00005768-198104000-00009.
8
Pharmacokinetics and bioavailability.药代动力学与生物利用度。
Triangle. 1975;14(3-4):101-8.
9
Pharmacokinetics in relation to age.与年龄相关的药代动力学。
Boll Chim Farm. 1973 May;112(5):333-41.
10
Influence of cholestasis on drug elimination: pharmacokinetics.胆汁淤积对药物消除的影响：药代动力学
J Pharm Sci. 1976 Sep;65(9):1346-8. doi: 10.1002/jps.2600650921.
引用本文的文献
1
A Modular Mathematical Model of the Immune Response for Investigating the Pathogenesis of Infectious Diseases.一种用于研究传染病发病机制的免疫反应模块化数学模型。
Viruses. 2025 Apr 22;17(5):589. doi: 10.3390/v17050589.
2
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics.基于蛋白质的降解剂：从化学生物学工具到新型疗法。
Chem Rev. 2025 Feb 26;125(4):2120-2183. doi: 10.1021/acs.chemrev.4c00595. Epub 2025 Jan 17.
3
Evaluating data for drug metabolism and transport: lessons from Kirchhoff's Laws.评估药物代谢和转运的数据：基尔霍夫定律的启示
Front Pharmacol. 2024 Nov 5;15:1456677. doi: 10.3389/fphar.2024.1456677. eCollection 2024.
4
Quantitative pulmonary pharmacokinetics of tetrandrine for SARS-CoV-2 repurposing: a physiologically based pharmacokinetic modeling approach.粉防己碱用于新型冠状病毒肺炎再利用的定量肺药代动力学：基于生理的药代动力学建模方法。
Front Pharmacol. 2024 Sep 13;15:1457983. doi: 10.3389/fphar.2024.1457983. eCollection 2024.
5
Commentary: Pharmacokinetic Theory Must Consider Published Experimental Data.述评：药代动力学理论必须考虑已发表的实验数据。
Drug Metab Dispos. 2024 Aug 14;52(9):932-938. doi: 10.1124/dmd.124.001735.
6
Uridine 5'-Diphospho-glucuronosyltransferase 1A3 (UGT1A3) Prediction of Hepatic Clearance of Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Substrate Telmisartan by Glucuronidation Using In Vitro-In Vivo Extrapolation (IVIVE).尿苷二磷酸葡萄糖醛酸转移酶 1A3（UGT1A3）预测通过葡萄糖醛酸化对有机阴离子转运多肽 1B3（OATP1B3）底物替米沙坦的肝清除率的体外-体内外推法（IVIVE）。
Eur J Drug Metab Pharmacokinet. 2024 May;49(3):393-403. doi: 10.1007/s13318-024-00895-3. Epub 2024 Apr 20.
7
Are all measures of liver Kp a function of F, as determined following oral dosing, or have we made a critical error in defining hepatic drug clearance?是否如口服给药后所确定的那样，肝脏Kp的所有测量值都是F的函数，或者我们在定义肝脏药物清除率时犯了一个关键错误？
Eur J Pharm Sci. 2024 May 1;196:106753. doi: 10.1016/j.ejps.2024.106753. Epub 2024 Mar 22.
8
A bimolecular modification strategy for developing long-lasting bone anabolic aptamer.一种用于开发长效骨合成适配体的双分子修饰策略。
Mol Ther Nucleic Acids. 2023 Nov 10;34:102073. doi: 10.1016/j.omtn.2023.102073. eCollection 2023 Dec 12.
9
Use of Clearance Concepts to Simulate Impact of Interleukin-6 on Drug Elimination Governed by Cytochromes P450 3A4 and Glomerular Filtration Rate.运用清除率概念模拟白细胞介素-6对由细胞色素P450 3A4和肾小球滤过率所介导的药物消除的影响。
Eur J Drug Metab Pharmacokinet. 2023 Nov;48(6):619-621. doi: 10.1007/s13318-023-00859-z. Epub 2023 Oct 4.
10
Chemical Reactions in Living Systems.生命体系中的化学反应。
Adv Sci (Weinh). 2024 Feb;11(8):e2303396. doi: 10.1002/advs.202303396. Epub 2023 Sep 7.
本文引用的文献
1
THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN.犬和人对取代马尿酸衍生物及其他芳香酸的肾清除率
J Clin Invest. 1945 May;24(3):388-404. doi: 10.1172/JCI101618.
2
Thiopental pharmacokinetics.硫喷妥钠的药代动力学。
J Pharm Sci. 1968 Aug;57(8):1346-51. doi: 10.1002/jps.2600570814.
3
Generalized solution to linear, to-compartment, open model for drug distribution.药物分布线性二室开放模型的广义解
J Theor Biol. 1970 Oct;29(1):63-8. doi: 10.1016/0022-5193(70)90119-0.
4
Application of clearance and volume of distribution to the plateau principle of drugs.清除率和分布容积在药物坪值原理中的应用。
J Pharm Sci. 1970 Oct;59(10):1423-7. doi: 10.1002/jps.2600591011.
5
A comparative study of drug metabolism in the isolated perfused liver and in vivo in rats.大鼠离体灌注肝脏与体内药物代谢的比较研究。
Eur J Pharmacol. 1970 Jan;9(1):99-105. doi: 10.1016/0014-2999(70)90326-2.
6
Preliminary model for methotrexate pharmacokinetics.甲氨蝶呤药代动力学的初步模型
J Pharm Sci. 1970 Feb;59(2):149-54. doi: 10.1002/jps.2600590203.
7
Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve.给药途径对血浆浓度-时间曲线下面积影响的药代动力学基础。
J Pharm Sci. 1969 Dec;58(12):1477-80. doi: 10.1002/jps.2600581211.
8
Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation and in vivo.清除概念在关于离体灌注肝脏制剂和体内药物代谢的一些文献数据中的应用。
Eur J Pharmacol. 1972 Mar;17(3):352-6. doi: 10.1016/0014-2999(72)90115-x.
9
Influence of route of administration on drug availability.给药途径对药物可利用性的影响。
J Pharm Sci. 1972 Jan;61(1):70-4. doi: 10.1002/jps.2600610111.
10
In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine.药物代谢的体外-体内相关性——1-β-D-阿拉伯呋喃糖基胞嘧啶的脱氨基作用
Biochem Pharmacol. 1972 Jan;21(1):1-16. doi: 10.1016/0006-2952(72)90245-6.
Zotero 插件